The Prognostic Role of Candidate Serum Biomarkers in the Post-Acute and Chronic Phases of Disorder of Consciousness: A Preliminary Study.

INTRODUCTION

Serum biomarkers, such as Neurofilament Light (NF-L), Glial Fibrillary Acidic Protein (GFAP), Ubiquitin C-terminal Hydrolase (UCH-L1), and Total-tau (T-Tau) have been proposed for outcome prediction in the acute phase of severe traumatic brain injury, but they have been less investigated in patients with prolonged DoC (p-DoC).

METHODS

We enrolled 25 p-DoC patients according to the Coma Recovery Scale-Revised (CRS-R). We identified different time points: injury onset (t), first blood sampling at admission in Neurorehabilitation (t), and second blood sampling at discharge (t). Patients were split into improved (improved level of consciousness from t to t) and not-improved (unchanged or worsened level of consciousness from t to t).

RESULTS

All biomarker levels decreased over time, even though each biomarker reveals typical features. Serum GFAP showed a weak correlation between t and t ( = 0.001), while no correlation was observed for serum NF-L ( = 0.955), UCH-L1 ( = 0.693), and T-Tau ( = 0.535) between t and t. Improved patients showed a significant decrease in the level of NF-L ( = 0.0001), UCH-L1 ( = 0.001), and T-Tau ( = 0.002), but not for serum GFAP ( = 0.283). No significant statistical differences were observed in the not-improved group.

CONCLUSIONS

A significant correlation was found between the level of consciousness improvement and decreased NF-L, UCH-L1, and T-Tau levels. Future studies on the association of serum biomarkers with neurophysiological and neuroimaging prognostic indicators are recommended.